Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
Statin use was associated with increased rates of diabetes in overweight and obese patients.
Postprandial hypoglycemia may occur after Roux-en-Y gastric bypass in patients with type 2 diabetes, independent from diabetes remission.
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
Dapaglifozin and vildagliptin impact cardio-metabolic processes differently.